EC

EcoR1 Capital Portfolio holdings

AUM $1.69B
This Quarter Return
+10.11%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$2.84B
AUM Growth
+$168M
Cap. Flow
+$31.6M
Cap. Flow %
1.11%
Top 10 Hldgs %
72.46%
Holding
82
New
9
Increased
14
Reduced
8
Closed
12

Top Buys

1
GLPG icon
Galapagos
GLPG
$82M
2
RCUS icon
Arcus Biosciences
RCUS
$62.3M
3
PTGX icon
Protagonist Therapeutics
PTGX
$25.6M
4
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
$25.2M
5
GRTS
Gritstone bio, Inc. Common Stock
GRTS
$23.1M

Top Sells

1
RLAY icon
Relay Therapeutics
RLAY
$97.8M
2
TBIO
Translate Bio, Inc. Common Stock
TBIO
$28.9M
3
NRIX icon
Nurix Therapeutics
NRIX
$25.2M
4
KYMR icon
Kymera Therapeutics
KYMR
$25.2M
5
ARVN icon
Arvinas
ARVN
$24.8M

Sector Composition

1 Healthcare 97.98%
2 Financials 0.69%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
TNGX icon
26
Tango Therapeutics
TNGX
$745M
$16.8M 0.58%
1,300,000
+500,000
+63% +$6.47M
BLUE
27
DELISTED
bluebird bio
BLUE
$15.3M 0.53%
+61,954
New +$15.3M
ERAS icon
28
Erasca
ERAS
$406M
$14.9M 0.52%
+700,000
New +$14.9M
CNTA
29
Centessa Pharmaceuticals
CNTA
$2.13B
$12.6M 0.44%
754,545
– –
SPRY icon
30
ARS Pharmaceuticals
SPRY
$1.08B
$11.8M 0.41%
1,184,710
-1,433,326
-55% -$14.3M
ODT
31
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$10.8M 0.38%
3,727,261
+2,896,061
+348% +$8.43M
CRVS icon
32
Corvus Pharmaceuticals
CRVS
$419M
$10.1M 0.35%
2,081,077
-1,498,300
-42% -$7.25M
IMVT icon
33
Immunovant
IMVT
$2.91B
$9.91M 0.34%
+1,140,819
New +$9.91M
NUVB.WS icon
34
Nuvation Bio Inc. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50
NUVB.WS
$63.9M
$9.58M 0.33%
963,333
– –
CCCC icon
35
C4 Therapeutics
CCCC
$182M
$8.94M 0.31%
200,000
– –
KRON
36
DELISTED
Kronos Bio
KRON
$8.12M 0.28%
387,357
– –
NGNE icon
37
Neurogene
NGNE
$284M
$6.22M 0.22%
43,031
-74,909
-64% -$10.8M
FLAC
38
DELISTED
Frazier Lifesciences Acquisition Corporation Class A Ordinary Shares
FLAC
$5.77M 0.2%
587,615
+387,120
+193% +$3.8M
ACIU icon
39
AC Immune
ACIU
$227M
$5.04M 0.18%
751,251
-1,896,912
-72% -$12.7M
CYCN icon
40
Cyclerion Therapeutics
CYCN
$7.77M
$4.93M 0.17%
80,314
– –
JYAC
41
DELISTED
Jiya Acquisition Corp. Class A Common Stock
JYAC
$4.88M 0.17%
500,000
– –
VERV
42
DELISTED
Verve Therapeutics
VERV
$4.7M 0.16%
100,000
– –
KNTE
43
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
$4.03M 0.14%
175,000
+150,000
+600% +$3.45M
OBIO icon
44
Orchestra BioMed
OBIO
$147M
$3.96M 0.14%
400,000
– –
PRDS
45
DELISTED
Pardes Biosciences, Inc. Common Stock
PRDS
$3.69M 0.13%
371,014
+221,014
+147% +$2.2M
DYN icon
46
Dyne Therapeutics
DYN
$1.92B
$3.57M 0.12%
215,000
– –
IGMS
47
DELISTED
IGM Biosciences
IGMS
$2.5M 0.09%
38,030
– –
FMTX
48
DELISTED
Forma Therapeutics Holdings, Inc. Common Stock
FMTX
$2.09M 0.07%
90,141
-15,497
-15% -$359K
BLSA
49
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$1.99M 0.07%
200,000
– –
MLTX icon
50
MoonLake Immunotherapeutics
MLTX
$3.78B
$1.99M 0.07%
200,000
– –
1
2
3 4